Medical Research News and Research

RSS

Safeway raises funds to support neuromuscular disease medical research and therapies

Safeway Inc. announced today it has raised a record $10.2 million to support medical research and services for the millions of people living with neuromuscular diseases. The funds were raised during Safeway’s annual Muscular Dystrophy Association (MDA) campaign, a five-week endeavor to highlight the need to find cures and treatments for muscular dystrophy and related diseases, and presented during the Jerry Lewis MDA Telethon in Las Vegas Labor Day weekend.

9 Sep 2009

Newly established McClay Foundation to encourage healthcare research in Northern Ireland

Speaking last week Sir Allen McClay, Chairman of the Almac Group, formally announced the establishment of the McClay Foundation, a charitable trust, one of the first of its kind in Northern Ireland.

8 Sep 2009

Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice

Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.

7 Sep 2009

CLU and PICALM genes associated with Alzheimer's disease

British scientists have discovered two new genes associated with Alzheimer's disease, while French colleagues uncovered a third. The results, from the largest ever Alzheimer's genome-wide association study (GWAS) involving 16,000 individuals, are published in Nature Genetics. They are the first new genes found to be associated with the common form of Alzheimer's disease since 1993.

7 Sep 2009

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.

4 Sep 2009

Brain screening tests may do more harm than good

Researchers warn that paid-for brain scans - increasingly popular with healthy people who want to allay fears about undiagnosed brain cancer and stroke - may do more harm than good.

4 Sep 2009

Implanet to use IBM's sensor technology for its new implant device tracking service

Implanet, a manufacturer of implantable medical devices, has selected IBM (NYSE: IBM) sensor technology as the foundation for BeepN'Track, a new service that traces the movement of Implanet's products - including knee and hip implants - across its supply chain to hospitals.

3 Sep 2009

Mosquito screens prevent malaria

Trials of a screen-based malaria prevention programme in 500 homes in The Gambia, Africa, have led to a 50 per cent reduction in malaria transmission and anaemia in children. A child dies from malaria in Africa every 30 seconds and infection can lead to an increased risk of anaemia, which can also prove fatal. Yet to date, screens have often been ignored in favour of using drugs and insecticides.

3 Sep 2009

Brain profiling tool to detect at-risk combat soldiers

According to a recent Washington Post study, approximately 20% of U.S. soldiers returning from Iraq and Afghanistan are psychologically damaged. Among them are a substantial number with post-traumatic stress disorder (PTSD), and the high rate of suicide among PTSD sufferers has become unacceptable to Army commanders and the soldiers' families.

3 Sep 2009

Public-private collaboration to fund research on health, diet and green technology

A total of £7M funding has been announced today by two public-private collaborations led by the Biotechnology and Biological Sciences Research Council (BBSRC).

2 Sep 2009

Induced antibodies neutralize HIV-1; recognize peptides encapsulated in liposomes

For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids. The results were reported by U.S. Military HIV Research Program (MHRP) researchers on Aug. 25 in the online version of AIDS, the official journal of the International AIDS Society.

2 Sep 2009

T cells influence aggressive immune cells by regulating the chemical environment between cells

University of Michigan scientists say they have uncovered a fundamentally new mechanism that holds in check aggressive immune cells that can attack the body's own cells. The findings open a new avenue of research for future therapies for conditions ranging from autoimmune diseases to organ transplants to cancer.

2 Sep 2009

New research on post-traumatic stress disorder to be presented at MHRF

New research on post-traumatic stress disorder (PTSD) is being presented this week at the Military Health Research Forum (MHRF), a scientific conference hosted by the Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). Depending on the conflict in which they served, 10 to 30 percent of soldiers who have spent time in war zones experience the debilitating and life-altering symptoms of post-traumatic stress disorder (PTSD).

2 Sep 2009

Human Tissue Act 2004 may have helped medical research involving human tissue

Fears that medical research using tissue such as blood or material from biopsies would be obstructed by the Human Tissue Act 2004 may have been unfounded, a new study from the University of Leicester reveals.

2 Sep 2009

Tel Aviv University researcher devises mathematical formula for protecting the genetic privacy

Last year, after a published paper found serious security holes in the way DNA data is made publicly available, health institutes in the United States and across the world removed all genetic data from public access.

1 Sep 2009

MRRI research study to investigate how zolpidem might restore consciousness for patients in the vegetative state

Moss Rehabilitation Research Institute (MRRI), the research arm of MossRehab, one of the world’s leading clinical rehabilitation centers, has launched an ambitious research study to investigate how the sleep drug zolpidem might restore consciousness for patients in the vegetative state.

31 Aug 2009

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Researchers today published promising results for a drug that could lead to a replacement for the very effective but difficult-to-use blood thinner Coumadin (sold generically as Warfarin), currently taken by millions of Americans to reduce their risk of stroke.

31 Aug 2009

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

Urine LAM-ELISA does not appear to be useful as an independent diagnostic test for pulmonary tuberculosis (TB). A trial of the new diagnostic, described in the open access journal BMC Infectious Diseases found that it was only capable of identifying 50.7% of TB cases.

28 Aug 2009

Enzymes could be targeted to kill dangerous pathogens

Researchers at Burnham Institute for Medical Research (Burnham), University of Texas Southwestern Medical Center and University of Maryland have demonstrated that an enzyme that is essential to many bacteria can be targeted to kill dangerous pathogens.

28 Aug 2009

Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

Kenya on Thursday launched a national malaria campaign to encourage Kenyans to sleep under insecticide-treated nets (ITNs) every night to prevent infection, the Daily Nation reports.

28 Aug 2009

Medical Research News and Research

Safeway raises funds to support neuromuscular disease medical research and therapies

Newly established McClay Foundation to encourage healthcare research in Northern Ireland

Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice

CLU and PICALM genes associated with Alzheimer's disease

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

Brain screening tests may do more harm than good

Implanet to use IBM's sensor technology for its new implant device tracking service

Mosquito screens prevent malaria

Brain profiling tool to detect at-risk combat soldiers

Public-private collaboration to fund research on health, diet and green technology

Induced antibodies neutralize HIV-1; recognize peptides encapsulated in liposomes

T cells influence aggressive immune cells by regulating the chemical environment between cells

New research on post-traumatic stress disorder to be presented at MHRF

Human Tissue Act 2004 may have helped medical research involving human tissue

Tel Aviv University researcher devises mathematical formula for protecting the genetic privacy

MRRI research study to investigate how zolpidem might restore consciousness for patients in the vegetative state

Clinical trial results of Dabigatran proves its effectiveness for treating atrial fibrillation

Urine LAM-ELISA's sensitivity of 50.7% in identifying TB disappoints

Enzymes could be targeted to kill dangerous pathogens

Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

A guide to advancing biotherapeutic research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News